EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutation type‐specific transcriptomic signatures and readthrough therapy rescue in SMC1A ‐related developmental and epileptic encephalopathy

Maddalena Di Nardo iD, Francesca Sardina iD, Maria M Pallotta iD, Iñigo Marcos-Alcalde iD, Paulino Gómez-Puertas iD, Cinzia Rinaldo iD, Ian D Krantz iD, Antonio Musio iD

Epilepsia · 2026-06 · 67 (6) · 3185-3198

DOI: 10.1002/epi.70150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 02.03.2026. Verfasst von Maddalena Di Nardo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Technologies, National Research Council, Pisa, Italy. Hauptthemen laut MEDLINE: Chromosomal Proteins, Non-Histone, Transcriptome, Cell Cycle Proteins, De Lange Syndrome. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Italian SMC1A Association, Spanish State Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to investigate the molecular consequences of pathogenic variants in the SMC1A gene—particularly those associated with developmental and epileptic encephalopathy (DEE85)—and to evaluate the therapeutic potential of ataluren in restoring SMC1A function and mitigating disease‐related transcriptomic and genomic alterations.

Methods

The study analyzed transcriptomic profiles from cell lines derived from individuals with DEE85 and Cornelia de Lange syndrome (CdLS), comparing the effects of different SMC1A variants. Particular focus was placed on nonsense variants and their impact on gene expression. Functional assays were conducted to assess the ability of ataluren to restore SMC1A protein expression, correct transcriptional defects, and reduce genomic instability.

Results

Transcriptomic alterations were strongly dependent on variant type, with nonsense variants causing the most profound gene expression changes. DEE85 and CdLS cell lines exhibited distinct transcriptional signatures. Treatment with ataluren led to successful restoration of SMC1A protein levels, partial correction of gene expression abnormalities, and a reduction in genomic instability in cells harboring nonsense variants. Significance These findings demonstrate that SMC1A ‐related epileptic encephalopathies are driven by variant‐specific molecular mechanisms and highlight the therapeutic promise of ataluren for DEE85. The study supports further development of precision medicine strategies targeting nonsense variants in SMC1A , with potential implications for improving diagnosis, treatment, and quality of life in affected individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosomal Proteins, Non-HistoneTranscriptomeCell Cycle ProteinsDe Lange SyndromeHumansStructural Maintenance of Chromosome Protein 1MutationEpilepsy

Stichwörter der Autor:innen

Cornelia de Lange syndromeSMC1Aatalurendevelopmental and epileptic encephalopathy (DEE85)transcriptomic profiles

Substanzen

Structural Maintenance of Chromosome Protein 1Chromosomal Proteins, Non-HistoneCell Cycle Proteins

Autor:innen und Institutionen

  • Institute of Biomedical Technologies, National Research Council, Pisa, Italy.
  • Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
  • Molecular Modeling Group, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid, Madrid, Spain.
  • Division of Pediatric Genetics and Genomics, Cohen Children's Medical Center, Northwell Health, Great Neck, New York, USA.
  • Department of Pediatrics, Zucker School of Medicine, Hofstra University, New York, New York, USA.

ORCID-Profile: Maddalena Di Nardo, Francesca Sardina, Maria M Pallotta, Iñigo Marcos-Alcalde, Paulino Gómez-Puertas, Cinzia Rinaldo, Ian D Krantz, Antonio Musio

Förderung

  • Ministero dell'Università e della Ricerca
  • Italian SMC1A Association
  • Spanish State Research Agency
  • Agencia Estatal de Investigación

Zitieren

APA

Di Nardo, M., Sardina, F., Pallotta, M. M., Marcos-Alcalde, I., Gómez-Puertas, P., Rinaldo, C., Krantz, I. D., & Musio, A. (2026). Mutation type‐specific transcriptomic signatures and readthrough therapy rescue in SMC1A ‐related developmental and epileptic encephalopathy. Epilepsia, 67(6), 3185-3198. https://doi.org/10.1002/epi.70150

Vancouver

Di Nardo M, Sardina F, Pallotta MM, Marcos-Alcalde I, Gómez-Puertas P, Rinaldo C, et al. Mutation type‐specific transcriptomic signatures and readthrough therapy rescue in SMC1A ‐related developmental and epileptic encephalopathy. Epilepsia. 2026;67(6):3185-3198. doi:10.1002/epi.70150

BibTeX
@article{DiNardo2026,
  author = {Di Nardo, Maddalena and Sardina, Francesca and Pallotta, Maria M and Marcos-Alcalde, Iñigo and Gómez-Puertas, Paulino and Rinaldo, Cinzia and Krantz, Ian D and Musio, Antonio},
  title = {Mutation type‐specific transcriptomic signatures and readthrough therapy rescue in SMC1A ‐related developmental and epileptic encephalopathy},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {6},
  pages = {3185--3198},
  doi = {10.1002/epi.70150}
}
Kostenlos starten →